Trial intelligence / Profile preview

Respiratory functions after busulfan conditioning in children

NCT00328029Phase 2Unknown

Sponsor
Strasbourg University Hospital
Start
Jul 2006
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of busulfan in hematological malignancy, Hematopathy, sponsored by Strasbourg University Hospital. Status: unknown.

02

Drugs

busulfan
03

Conditions

hematological malignancyHematopathy

Beyond the preview

Go deeper on NCT00328029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00328029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call